| Financial Year |
March 31 2023 |
| Monetary Funds |
1,010,326,594.35 |
| Held-for-trading Financial Assets |
15,323,655.28 |
| Notes Receivable |
62,206,370.20 |
| Accounts Receivable |
342,408,859.99 |
| Advances to Suppliers |
49,377,946.42 |
| Other Receivables |
12,624,657.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
764,998,140.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,675,412.37 |
| Total Current Assets |
2,331,885,668.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
893,899,818.46 |
| Investment Properties |
1,152,145.81 |
| Fixed Assetes |
978,809,283.43 |
| Under-construction Projects |
724,277,202.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
413,016,826.48 |
| R&D expenses |
144,498,711.17 |
| Goodwill |
485,687,223.66 |
| Long-Term Deferred and Prepaid Expenses |
2,279,404.78 |
| Deferred Income Tax Assets |
95,195,549.50 |
| Other Non-Current Assets |
28,187,747.04 |
| Sub-Total of Non-Current Assets |
3,963,495,500.28 |
| Total Assets |
6,295,381,169.09 |
| Short-Term Loans |
633,942,472.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,249,000.00 |
| Accounts Payable |
279,204,713.72 |
| Accounts Received In Advance |
3,774,839.18 |
| Employee Compensation Payable |
12,968,418.33 |
| Taxes Payable |
25,368,421.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
277,919,919.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,556,748.08 |
| Other Current Liabilities |
71,740,730.71 |
| Sub-Total of Current Liabilities |
1,404,417,023.50 |
| Long-term Loans |
514,641,731.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,937,994.65 |
| Other Non-Current Liabilities |
177,274,559.89 |
| Sub-Total of Non-Current Liabilities |
853,636,236.37 |
| Total Liabilities |
2,258,053,259.87 |
| Paid-In Capital(Or Share Stock) |
1,189,712,382.00 |
| Capital Surplus |
2,227,433,756.62 |
| Surplus Reserve |
77,570,228.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
567,978,572.15 |
| Minority Stockholder's Interest |
3,606,665.35 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,033,721,243.87 |
| Owner's Equity（Stockholder's Equity） |
4,037,327,909.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,295,381,169.09 |
